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microalbuminuria may not be necessarily a component
of the metabolic syndrome [3].
Finally, on the basis of other studies, one may speculate
that chronic inflammation may be the underlying mech-
anism that explains the association of hepatic C with mi-
croalbuminuria because atherosclerosis itself appears to
be an inflammatory disorder [4, 5].
In their study, markers of inflammation such as IL-6
and C-reactive protein were not measured.
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Reply from the Authors
We are very grateful to Dr. Nzerue for his thoughtful
comments on our paper [1]. In this correspondence, we
respond to thoughtful queries by Dr. Nzerue.
First, in our discussion, we admitted that a single mea-
surement of urine albumin to creatinine ratio to assess
for the presence of microalbuminuria is not ideal. Unfor-
tunately, the NHANES III is a cross-sectional study and
sequential urinary data were not available.
Second, Dr. Nzerue points out that there is not a con-
sistent relationship between the metabolic syndrome and
microalbuminuria in some age groups, and this may ex-
plain why we failed to observe an association between
hepatitis C and the metabolic syndrome. While this is
plausible, more rigorous studies are needed to examine
this issue as our results disagree with a previous retrospec-
tive cohort study [2], which showed a high prevalence of
the metabolic syndrome in patients with hepatitis C.
Third, we accept the possibility that chronic inflamma-
tion or immune processes are involved in the pathogen-
esis of microalbuminuria in hepatitis C subjects. We ex-
plored this possibility, but found that cryoglobulin levels
were not measured in the NHANES III, and rheumatoid
factor data were missing in most patients in the hepatitis
C cohort. However, we failed to find any differences in
the levels of C-reactive protein in subjects with hepatitis
C and controls (0.41 ± 0.62 vs. 0.44 ± 0.86 mg/dL, P =
0.5).
Our study should be viewed as exploratory in na-
ture and our observations require validation in ongo-
ing prospective studies (e.g., NIDDK-funded Virahep-C
study).
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Red blood cell deformability
and diabetic nephropathy
To the editor: In an interesting study, Brown et al [1]
found an impaired red blood cell deformability in 57 adult
type 2 diabetic patients. They used a filtration technique
using polycarbonate membranes with straight channels
of 3 micrometer pore diameter. In patients with diabetic
nephropathy they found an increased impairment in red
blood cell deformability. The hypothesis that an impaired
red blood cell deformability contributes to renal function
decline is very attractive and may give rise to therapeutic
possibilities. Many studies found an impaired red blood
cell deformability in diabetic patients; others, however,
did not. Years ago we tested the hypothesis that red blood
cell deformability contributes to diabetic nephropathy us-
ing both ektacytometry and erythrocyte filtration, with
micropores with a diameter of 5 micrometer [2]. In or-
der to imitate local circumstances in the kidney red blood
cell, deformability was also measured in hyperosmolar so-
lutions. Seventy-one insulin-dependent diabetic patients
were included, 25 patients without any sign of organ dam-
age, 21 patients with microalbuminuria, 13 patients with
overt nephropathy, and 12 patients with leg ulceration.
No decreased red blood cell deformability was found in
any of the diabetic groups with either technique, neither
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did the total group of 71 diabetic patients have a lower
red blood cell deformability when compared to controls.
Extaerythrocytic factors, such as leukocytes, plasma fib-
rinogen, and platelet microaggregates may influence fil-
tration results. I suppose the filtration technique of Brown
et al was corrected for this. These results may suggest that
the filtration pore size of 3 micrometers used by Brown et
al was more sensitive than the 5 micrometer pores filtra-
tion technique and ektacytometry that was used by us and
that the lack of difference in our patient groups reflects
this lack of sensitivity. On the other hand, the question
arises whether such subtle differences in red blood cell
deformability, if present, contribute to nephropathy in
diabetic patients.
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Reply from the Authors
We wish to thank Dr. Schut for their interest in our
study [1], and would like to reply to the issues raised in
their letter to the Editor.
We think that the results of our study do not agree with
those reported in their article published in 1993 [2] for
reasons stated in their letter. For example, we removed
leukocytes and platelets before measuring RBC deforma-
bility (RBC-df), and we opted to use the more sensitive
3 micron pore filter instead of a 5 micron pore filter.
To address the question of whether changes in RBC-
df contributes to diabetic nephropathy, we do not know
whether impaired RBC-df is a cause or consequence of
diabetic nephropathy.
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Postprocedural drop in
hematocrit versus
contrast-induced nephropathy:
Eggs or chickens?
To the Editor: In a recent issue of Kidney International,
Nikolsky et al suggested that low hematocrit (Hct) pre-
dicts contrast-induced nephropathy (CIN) after percuta-
neous coronary interventions (PCI) [1]. One impressive
finding in this study was that the postprocedural drop
in Hct (Hct = baseline Hct − postprocedural nadir
Hct) was highly correlated with CIN. However, we won-
der whether Hct resulted in CIN or, on the contrary,
it was attributed to CIN. Assuming that there was no
significant postprocedural change of body weight (BW)
or fluid status in the patients receiving PCI, Hct might
exactly reflect acute blood loss. The most possible route
of the blood loss was extravascular loss (e.g., bleeding,
hematoma, catheter aspiration, etc.) rather than intravas-
cular hemolysis. Hence, the amount of the procedure-
related extravascular blood loss (EVBL) could be esti-
mated by the following equations [2]:
Blood volume = plasma volume/(1 − Hct) = BW
× (60% × 40% × 20%)/(1 − Hct);
EVBL (L) = BW (kg) × (60% × 40% × 20%)
× Hct/[(1 − baseline Hct)
(1 − baseline Hct + Hct)]
In a male patient with a BW of 70 kg, baseline Hct
40%, Hct 6%, his estimated EVBL would be 510 mL.
Actually, the average amount of EVBL after PCI rarely
exceeded 100∼200 mL. This could not explain the large
gap from the estimated data. On the contrary, Hct might
also be attributed to fluid retention-induced hemodi-
lution secondary to CIN. The proportional increase of
serum creatinine must overcome the dilute effect of
acute fluid retention before meeting the definition of
CIN (i.e., an increase of ≥25% or ≥0.5 mg/dL in pre-
PCI serum creatinine at 48 hours post-PCI) [3, 4]. Precise
